Making the Invisible, Visible
What constitutes meaningful quality of life from the perspective of a patient with advanced IPF?
Every patient will have a different idea of what it means for them to live a quality life with idiopathic pulmonary fibrosis (IPF). This video explores how clinicians and patients differ about what they think constitutes a meaningful quality of life (QoL). Understanding these gaps could help you to consider what management techniques can support your patient's quality of life.
Related Content
Critical threat of fibrotic ILDs
Pulmonary fibrosis is a critical threat across a broad range of ILDs.2–5
Increased mortality rates
Pulmonary fibrosis is a key driver of early mortality in patients with fibrotic ILDs.5–8
ILD patient cases for evaluation and diagnosis
Download our patient cases: medical histories of representative patients.
Resources for patients
Helping patients and their loved ones to learn more about their condition.
Providing information and resources to help support and guide patients.
- Flaherty KR, Brown KK, Wells AU, et al. Design of the PF-ILD trial: A double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ Open Resp Res. 2017;4(1):e000212
- Patterson KC, Strek ME. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Ann Am Thorac Soc. 2013;10(4):362-370.
- Caban JJ, Yao J, Bagci U, Mollura DJ. Monitoring pulmonary fibrosis by fusing clinical, physiological, and computed tomography features. Conf Proc IEEE Eng Med Biol Soc. 2011;6216-6219.
- Wells AU, Brown KK, Flaherty KR, Kolb M, Thannickal VJ, on behalf of the IPF Consensus Working Group. Eur Resp J. 2018;51:1800692.
- Fischer A and Distler J. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases. Clin Rheumatol. 2019;38(10):2673–2681.
- Mathai SC and Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819.
- Wallace B, Vummidi D, Khanna D. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature. Curr Opin Rheumatol. 2016;28(3):236–245.
- Spagnolo P, Cordier JF, Cottin V. Connective tissue diseases, multimorbidity and the ageing lung. Eur Respir J. 2016;47(5):1535–1558.